ENTRY       D11747                      Drug
NAME        Inbakicept (USAN/INN)
FORMULA     C2980H4624N800O894S28
EXACT_MASS  66817.3138
MOL_WEIGHT  66859.2442
SEQUENCE    ITCPPPMSVE HADIWVKSYS LYSRERYICN SGFKRKAGTS SLTECVLNKA TNVAHWTTPS
            LKCIREPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED
            PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA
            PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN
            YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Disulfide bridge: 3-45, 29-63, 76-76', 79-79', 111-171, 217-275, 3'-45', 29'-63', 111'-171', 217'-275')
  TYPE      Peptide
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic
TARGET      PDL1 (CD274) [HSA:29126] [KO:K06745]
            IL15RA (CD215) [HSA:3601] [KO:K05074]
  PATHWAY   hsa04060(3601)  Cytokine-cytokine receptor interaction
            hsa04514(29126)  Cell adhesion molecules
            hsa04630(3601)  JAK-STAT signaling pathway
            hsa05200(3601)  Pathways in cancer
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D11747  Inbakicept
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL15RA (CD215)
                 D11747  Inbakicept (USAN/INN)
             Cell surface molecules and ligands
              Other cell surface molecules
               Immune checkpoints
                PDL1 (CD274)
                 D11747  Inbakicept (USAN/INN)
DBLINKS     CAS: 2135939-52-3
            PubChem: 405226613
///
